What to Look for in Bed Bath & Beyond Earnings
Bed Bath & Beyond is scheduled to release its fiscal first-quarter financial results after the markets close on Wednesday.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) is scheduled to release its fiscal first-quarter financial results after the markets close on Wednesday. Consensus estimates from Thomson Reuters call for $0.86 in earnings per share (EPS) on $2.78 billion in revenue. That would compare with the $0.93 in EPS on $2.74 billion posted in the same period of last year.
This retail giant of household products has been public for almost 25 years now. Bed Bath & Beyond had a very strong growth story for years, but that was before its recent spate of problems meeting earnings estimates or keeping guidance up. The company has turned to stock buybacks to boost earnings and shrink its float, but it gets to keep buying back stock at lower and lower share prices due to those disappointing headwinds.
Bed Bath & Beyond shares peaked at roughly $70 but had dipped back to under $50 by the start of 2016 and mostly stayed there so far this year. Analysts have seemingly thrown in the towel and revenue growth has all but stalled. Still, with $5.00 or more in EPS power and only $1.5 billion in long-term debt, this retail giant needs to start paying a dividend now that its growth prospects seem to have peaked.
[nativounit
Prior to the release of the earnings report, a few analysts weighed in on the company:
- Longbow Research initiated coverage with a Neutral rating.
- Credit Suisse initiated coverage with a Hold rating.
- Merrill Lynch reiterated a Sell rating.
- Nomura reiterated a Neutral rating with a $50 price target.
- Wedbush reiterated a Neutral rating with a $46 price target.
- Barclays reiterated an Equal Weight rating with a $50 price target.
- BTIG initiated coverage with a Neutral rating.
So far this year, Bed Bath & Beyond has underperformed the broad markets, with the stock down about 10%. Over the past year, the stock is down as much as 38%.
Shares of Bed Bath & Beyond were trading at $43.64 on Wednesday. The stock has a consensus analyst price target of $47.74 and a 52-week trading range of $41.26 to $71.20.
[wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
